Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples